🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Download a copy here: bit.ly/2BnJ3wj

Great resource that is fact based, up to date, and well presented. Anyone who is trying to make decisions about returning to school should invest the 45 mins and listen! ⁦IDSA⁩ idsociety.org/Podcasts/video…

Incredibly excited that this article is now published online! Our rockstar ambulatory care pharmacists are amazing partners in stewardship & having a huge impact on outpatient antibiotic prescribing! #DreamTeam @Kayla_Wren216 @KmJohnson_ Selena Pham japha.org/article/S1544-…

Procal or not? Comparison of procalcitonin testing to a targeted audit-and-feedback strategy. Congratulations to our just-graduated PGY1 resident, Lauren, & preceptor team! Had to share again because it’s posted for FREE on DMID until the end of the year! sciencedirect.com/science/articl…

(1/4) Poster #99: Comparison of Procalcitonin Testing to a Targeted Audit-and Feedback Strategy on Prescribed Durations of Therapy for CAP. Presented by: Dr. Lauren T Clark Lisa Dumkow Paige Buss Thomas Beuschel Andrew Jameson #IDWeek2020 cdmcd.co/8gKQ7v

Mercy Health Colleague Spotlight</strong> mercyhealthnews.com/2021/02/05/mer…

An OFID study finds no difference in treatment-associated complications btwn patients w/ community-acquired intra-abdominal infections treated w/ antipseudomonal or narrow-spectrum regimens: bit.ly/3wOIBzc Paul Sax Jonathan Li FungalDoc: moved to bluesky Lacy Worden @LisaIDPharmD

Almost 1 in 4 hospitalized patients (22%) in MI has #COVID19 When hospitals are > capacity Care for ALL patients is compromised Mortality ⬆️ for ALL patients - COVID and non-COVID. This is largely preventable. #GetVaccinatedNow 💉

‼️Out now in Open Forum Infectious Diseases - we compare BID to QID cephalexin for uUTI & found no difference in treatment failure! Excited to see this out & help teams minimize dosing frequency & improving patient experience! Shoutout to the best research team, Andrew Jameson & Kristen Eid Trinity Health Grand Rapids Pharmacy Residency

📣Excited to see this in ASHE Journal! No difference in patient outcomes using PO Amox or Cephalexin 1g TID compared to FQ & TMP/SMX for definitive bacteremia treatment from urinary source. Congrats Abby Geyer & team Andrew Jameson Trinity Health Grand Rapids Pharmacy Residency Thank you Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 for posting!

We escaped!! What a fun way to learn and team build! Hats off to the IDWeekOutBREAK planners, you knocked this out of the park! #IDWeek2023 #BestBuggies

⚠️Excited to share our team’s evaluation of transmission-based precautions following +RVP for non-COVID respiratory viruses. Has your site evaluated TBP appropriateness following the peak of SARS-CoV-2? Significant need for continuous, dedicated IP surveillance & education 🦠😷